TrkA-IN-9, CAS [[1802770-18-8]] Preis auf Anfrage

Produktübersicht

• Artikelname: TrkA-IN-9, CAS [[1802770-18-8]] Preis auf Anfrage
• Artikelnummer: BYT-ORB3028744
• Hersteller Artikelnummer: orb3028744
• Alternativnummer: BYT-ORB3028744-10, BYT-ORB3028744-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien

Produktbeschreibung

TrkA-IN-9 (VMD-928) is an orally active and selective inhibitor of tropomyosin receptor kinase A (TrkA). It disrupts downstream signaling pathways activated by nerve growth factor (NGF) binding to TrkA, thereby inhibiting cell proliferation and invasion, and promoting cancer cell death. TrkA-IN-9 shows potential for research in various cancers, including prostate cancer, thymic carcinoma, mesothelioma, head and neck squamous cell carcinoma, lung cancer, ovarian cancer, and hepatocellular carcinoma.

Produkteigenschaften

• Molekulargewicht: 524.61
• CAS Nummer: [1802770-18-8]
• Formel: C31H32N4O4
• Target-Kategorie: Trk receptor